Systematic review / meta-analysis / 2021
Former elite athletes were linked to longer lifespans and lower rates of CVD and cancer mortality compared to the general population.
A meta-analysis of 24 studies examined long-term mortality in former elite athletes categorized by endurance, mixed/team, or power sports. Former athletes lived significantly longer than the general population (male SMR 0.69 [95% CI 0.61-0.78]; female SMR 0.51 [95% CI 0.40-0.65]; both p < 0.01), though no survival benefit was observed for male power athletes (SMR 1.04 [95% CI 0.91-1.12]). Male athletes had significantly reduced CVD mortality (SMR 0.73 [95% CI 0.62-0.85]) and cancer mortality (SMR 0.75 [95% CI 0.63-0.89]), but risk reductions were not seen for power athletes' CVD mortality or endurance athletes' cancer mortality. Data were insufficient to calculate female sport-specific SMRs.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of cohort studies
- Who was studied
- 165,000 former elite athletes across 44 systematic review and 24 meta-analysis studies
- What was measured
- All-cause mortality, cardiovascular disease (CVD) mortality, and cancer mortality
THE PAPER
Health Consequences of an Elite Sporting Career: Long-Term Detriment or Long-Term Gain? A Meta-Analysis of 165,000 Former Athletes.
Runacres A, Mackintosh KA, McNarry MA. Sports Med, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.